FDA Names New Chief Operating Officer, Shifts Woodcock

WASHINGTON (Dow Jones)–The Food and Drug Administration Friday named John Dyer as the agency’s chief operating officer and deputy commissioner for operations.

Dyer held a similar position at the Centers for Medicare and Medicaid Services.

The agency also said Janet Woodcock, the most recent FDA deputy commissioner for operations, would be a deputy commissioner overseeing a new office of chief medical officer. In that role, Woodcock will oversee scientific and planning-related operations for FDA.

Dyer will help oversee FDA’s management processes and information technology.

By Jennifer Corbett Dooren, Dow Jones Newswires